Characterization of the receptor-ligand pathways important for entry and survival of Francisella tularensis in human macrophages.
Inhalational pneumonic tularemia, caused by Francisella tularensis, is lethal in humans. F. tularensis is phagocytosed by macrophages followed by escape from phagosomes into the cytoplasm. Little is known of the phagocytic mechanisms for Francisella, particularly as they relate to the lung and alveolar macrophages. Here we examined receptors on primary human monocytes and macrophages which mediate the phagocytosis and intracellular survival of F. novicida. F. novicida association with monocyte-derived macrophages (MDM) was greater than with monocytes. Bacteria were readily ingested, as shown by electron microscopy. Bacterial association was significantly increased in fresh serum and only partially decreased in heat-inactivated serum. A role for both complement receptor 3 (CR3) and Fcgamma receptors in uptake was supported by studies using a CR3-expressing cell line and by down-modulation of Fcgamma receptors on MDM, respectively. Consistent with Fcgamma receptor involvement, antibody in nonimmune human serum was detected on the surface of Francisella. In the absence of serum opsonins, competitive inhibition of mannose receptor (MR) activity on MDM with mannan decreased the association of F. novicida and opsonization of F. novicida with lung collectin surfactant protein A (SP-A) increased bacterial association and intracellular survival. This study demonstrates that human macrophages phagocytose more Francisella than monocytes with contributions from CR3, Fcgamma receptors, the MR, and SP-A present in lung alveoli.
Balagopal
Ashwin
A
Department of Internal Medicine, Ohio State University, 420 W. 12th Avenue, 216 Tzagournis Medical Research Facility, Columbus, OH 43210, USA.
MacFarlane
Amanda Shearer
AS
Mohapatra
Nrusingh
N
Soni
Shilpa
S
Gunn
John S
JS
Schlesinger
Larry S
LS
D000907:Antibodies, Bacterial / Q000097:blood; D005604:Francisella tularensis / Q000276:immunology* / Q000648:ultrastructure; D006801:Humans; D037181:Lectins, C-Type / Q000502:physiology; D008024:Ligands; D008168:Lung / Q000276:immunology; D016177:Macrophage-1 Antigen / Q000502:physiology; D008264:Macrophages / Q000276:immunology / Q000382:microbiology*; D000090323:Mannose Receptor; D037241:Mannose-Binding Lectins / Q000502:physiology; D046529:Microscopy, Electron, Transmission; D009000:Monocytes / Q000276:immunology / Q000382:microbiology; D010587:Phagocytosis; D018410:Pneumonia, Bacterial / Q000276:immunology*; D037662:Pulmonary Surfactant-Associated Protein A / Q000502:physiology; D011956:Receptors, Cell Surface / Q000502:physiology*; D017452:Receptors, IgG / Q000502:physiology; D044967:Serum / Q000276:immunology; D014406:Tularemia / Q000276:immunology*
D000907:Antibodies, Bacterial; D037181:Lectins, C-Type; D008024:Ligands; D016177:Macrophage-1 Antigen; D000090323:Mannose Receptor; D037241:Mannose-Binding Lectins; D037662:Pulmonary Surfactant-Associated Protein A; D011956:Receptors, Cell Surface; D017452:Receptors, IgG